More and more research is demonstrating the efficacy of psychedelic drugs for treating mental health disorders such as depression or post-traumatic stress disorder (PTSD). In addition, medical cannabis is showing potential for treating a wide variety of conditions, such as pain, anxiety, and depression.
On February 1, 2023, at 11:00 AM (ET), we are holding a panel discussion on this emerging area of treatment. Hosted by Cantor Fitzgerald’s Pablo Zuanic, speakers include:
• Payton Nyquvest, CEO, Numinus
• Klee Irwin, CEO, Irwin Naturals
• Ronan Levy, CEO, Field Trip Health
• Pablo Zuanic, Managing Director, Cantor Fitzgerald (Host)
Contact your #Cantor representative for more details.